Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness
Public ClinicalTrials.gov record NCT04870606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Outpatients With Mild to Moderate COVID-19 Illness
Study identification
- NCT ID
- NCT04870606
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Industry
- Enrollment
- 733 participants
Conditions and interventions
Conditions
Interventions
- Proxalutamide (GT0918) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 4, 2021
- Primary completion
- Jan 23, 2022
- Completion
- Apr 5, 2022
- Last update posted
- Jan 1, 2024
2021 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Absolute Clinical Research | Phoenix | Arizona | 85051 | — |
| Long Beach Clinical Trials | Long Beach | California | 90806 | — |
| WR-Mount Vernon Clinical Research, LLC | Sandy Springs | Georgia | 29677 | — |
| Olivo Medical and Wellness Center | Chicago | Illinois | 60618 | — |
| Gtc Research | Shawnee Mission | Kansas | 66218 | — |
| Platinum Research Network, LLC | Metairie | Louisiana | 70006 | — |
| Main Street Physician's Care | Little River | South Carolina | 29566 | — |
| Lotus Clinical Research | Houston | Texas | 77024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04870606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 1, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04870606 live on ClinicalTrials.gov.